tradingkey.logo

Haemonetics Corp

HAE
71.400USD
+0.920+1.31%
Horarios del mercado ETCotizaciones retrasadas 15 min
3.34BCap. mercado
19.85P/E TTM

Haemonetics Corp

71.400
+0.920+1.31%

Más Datos de Haemonetics Corp Compañía

Haemonetics Corporation is a global healthcare company. The Company is engaged in providing a suite of medical products and solutions for customers, to help them improve patient care and reduce the cost of healthcare. The Company’s technology addresses various medical markets, including blood and plasma component collection, the surgical suite, and hospital transfusion services. The Company’s Plasma segment includes plasma collection devices and disposables, donor management software and supporting software solutions sold to plasma customers. Its Blood Center segment manufactures and provides customers with its full line of apheresis solutions for automated blood collection. The Company’s Hospital segment consists of Interventional Technologies, which includes Vascular Closure, Sensor Guided Technologies and Esophageal Protection products, and Blood Management Technologies, which includes Hemostasis Management, Cell Salvage and Transfusion Management products.

Información de Haemonetics Corp

Símbolo de cotizaciónHAE
Nombre de la empresaHaemonetics Corp
Fecha de salida a bolsaOct 17, 1979
Director ejecutivoMr. Christopher A. Simon
Número de empleados3023
Tipo de seguridadOrdinary Share
Fin del año fiscalOct 17
Dirección125 Summer Street
CiudadBOSTON
Bolsa de valoresNYSE Consolidated
PaísUnited States of America
Código postal02110
Teléfono17818487100
Sitio Webhttps://www.haemonetics.com
Símbolo de cotizaciónHAE
Fecha de salida a bolsaOct 17, 1979
Director ejecutivoMr. Christopher A. Simon

Ejecutivos de Haemonetics Corp

Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Ms. Laurie A. Miller
Ms. Laurie A. Miller
Chief Human Resources Officer, Senior Vice President
Chief Human Resources Officer, Senior Vice President
28.01K
-0.84%
Mr. Charles J. Dockendorff, CPA
Mr. Charles J. Dockendorff, CPA
Independent Director
Independent Director
25.04K
+12.05%
Mr. Robert E. Abernathy
Mr. Robert E. Abernathy
Independent Director
Independent Director
24.98K
+12.08%
Dr. Mark W. Kroll, Ph.D.
Dr. Mark W. Kroll, Ph.D.
Independent Director
Independent Director
23.36K
+13.03%
Ms. Michelle L. Basil, J.D.
Ms. Michelle L. Basil, J.D.
Executive Vice President, General Counsel
Executive Vice President, General Counsel
19.69K
+2.11%
Ms. Ellen M. Zane
Ms. Ellen M. Zane
Independent Chairman of the Board
Independent Chairman of the Board
19.37K
+16.15%
Mr. Michael J. Coyle
Mr. Michael J. Coyle
Independent Director
Independent Director
15.39K
+21.20%
Ms. Diane M. Bryant
Ms. Diane M. Bryant
Independent Director
Independent Director
7.13K
+60.75%
Mr. Roy Galvin
Mr. Roy Galvin
Executive Vice President, Chief Commercial Officer
Executive Vice President, Chief Commercial Officer
3.24K
-4.28%
Mr. Frank W. Chan
Mr. Frank W. Chan
Chief Operating Officer, Executive Vice President
Chief Operating Officer, Executive Vice President
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Ms. Laurie A. Miller
Ms. Laurie A. Miller
Chief Human Resources Officer, Senior Vice President
Chief Human Resources Officer, Senior Vice President
28.01K
-0.84%
Mr. Charles J. Dockendorff, CPA
Mr. Charles J. Dockendorff, CPA
Independent Director
Independent Director
25.04K
+12.05%
Mr. Robert E. Abernathy
Mr. Robert E. Abernathy
Independent Director
Independent Director
24.98K
+12.08%
Dr. Mark W. Kroll, Ph.D.
Dr. Mark W. Kroll, Ph.D.
Independent Director
Independent Director
23.36K
+13.03%
Ms. Michelle L. Basil, J.D.
Ms. Michelle L. Basil, J.D.
Executive Vice President, General Counsel
Executive Vice President, General Counsel
19.69K
+2.11%
Ms. Ellen M. Zane
Ms. Ellen M. Zane
Independent Chairman of the Board
Independent Chairman of the Board
19.37K
+16.15%

Desglose de ingresos

Divisa: USDActualizado: lun., 6 de oct
Divisa: USDActualizado: lun., 6 de oct
FY2026Q1
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2021
FY2020
FY2019
Sin datos
Por regiónUSD
Nombre
Ganancia
Proporción
United States
242.40M
75.42%
Europe
40.88M
12.72%
Asia
21.65M
6.74%
Japan
13.65M
4.25%
other
2.81M
0.87%
Por negocio
Por región
Sin datos

Estadísticas de accionistas

Actualizado: sáb., 8 de nov
Actualizado: sáb., 8 de nov
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
BlackRock Institutional Trust Company, N.A.
11.90%
The Vanguard Group, Inc.
10.30%
Neuberger Berman, LLC
9.14%
Wellington Management Company, LLP
4.59%
State Street Investment Management (US)
4.02%
Otro
60.05%
Accionistas
Accionistas
Proporción
BlackRock Institutional Trust Company, N.A.
11.90%
The Vanguard Group, Inc.
10.30%
Neuberger Berman, LLC
9.14%
Wellington Management Company, LLP
4.59%
State Street Investment Management (US)
4.02%
Otro
60.05%
Tipos de accionistas
Accionistas
Proporción
Investment Advisor
52.23%
Investment Advisor/Hedge Fund
49.81%
Research Firm
4.18%
Hedge Fund
3.57%
Bank and Trust
1.38%
Pension Fund
1.36%
Individual Investor
1.19%
Sovereign Wealth Fund
1.10%
Insurance Company
0.03%

Participación institucional

Actualizado: mié., 1 de oct
Actualizado: mié., 1 de oct
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q3
697
54.60M
116.65%
-5.18M
2025Q2
700
57.31M
118.95%
-4.19M
2025Q1
723
57.94M
120.44%
-3.07M
2024Q4
701
58.48M
116.40%
-1.44M
2024Q3
689
57.60M
112.60%
-1.51M
2024Q2
668
57.60M
113.31%
+3.07M
2024Q1
655
52.49M
103.35%
-1.26M
2023Q4
647
51.85M
102.19%
-3.31M
2023Q3
657
52.00M
102.54%
-4.11M
2023Q2
656
51.75M
102.38%
-4.68M
Ver más

Actividad de los accionistas

Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
BlackRock Institutional Trust Company, N.A.
5.57M
11.56%
-96.61K
-1.71%
Jun 30, 2025
The Vanguard Group, Inc.
4.94M
10.26%
-145.60K
-2.86%
Jun 30, 2025
Neuberger Berman, LLC
4.28M
8.88%
-70.91K
-1.63%
Jun 30, 2025
Wellington Management Company, LLP
2.15M
4.46%
-478.59K
-18.23%
Jun 30, 2025
State Street Investment Management (US)
1.88M
3.91%
-34.03K
-1.77%
Jun 30, 2025
River Road Asset Management, LLC
1.66M
3.44%
+260.62K
+18.68%
Jun 30, 2025
T. Rowe Price Investment Management, Inc.
1.59M
3.31%
-600.70K
-27.36%
Jun 30, 2025
Royce Investment Partners
1.27M
2.64%
+109.76K
+9.45%
Jun 30, 2025
Geode Capital Management, L.L.C.
1.24M
2.58%
+23.26K
+1.90%
Jun 30, 2025
Capital Research Global Investors
1.14M
2.36%
-438.28K
-27.79%
Jun 30, 2025
Ver más

ETFs relacionados

Actualizado: dom., 2 de nov
Actualizado: dom., 2 de nov
Nombre
Proporción
SPDR S&P Health Care Equipment ETF
1.49%
Harbor Human Capital Factor US Small Cap ETF
1.48%
Neuberger Berman Small-Mid Cap ETF
1.36%
First Trust Mid Cap US Equity Select ETF
0.68%
First Trust Small Cap US Equity Select ETF
0.64%
Lattice Hartford Multifactor Small Cap ETF
0.51%
WisdomTree US SmallCap Quality Growth Fund
0.29%
VictoryShares US Small Mid Cap Value Momentum ETF
0.26%
Royce Quant Small-Cap Quality Value ETF
0.25%
First Trust Small Cap Growth AlphaDEX Fund
0.24%
Ver más
SPDR S&P Health Care Equipment ETF
Proporción1.49%
Harbor Human Capital Factor US Small Cap ETF
Proporción1.48%
Neuberger Berman Small-Mid Cap ETF
Proporción1.36%
First Trust Mid Cap US Equity Select ETF
Proporción0.68%
First Trust Small Cap US Equity Select ETF
Proporción0.64%
Lattice Hartford Multifactor Small Cap ETF
Proporción0.51%
WisdomTree US SmallCap Quality Growth Fund
Proporción0.29%
VictoryShares US Small Mid Cap Value Momentum ETF
Proporción0.26%
Royce Quant Small-Cap Quality Value ETF
Proporción0.25%
First Trust Small Cap Growth AlphaDEX Fund
Proporción0.24%

Dividendos

Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos

División de acciones

Fecha
Tipo
Relación
Sin datos
Fecha
Tipo
Relación
Sin datos
KeyAI